Patent · US Active

Positively charged polysaccharides for RNA transfection

US9566346B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignees

Inventors

Joseph Kost · Charleston, US
Riki Goldbart · Rahat, IL
Tamar Traitel · Beer Sheva, IL
Eliz Lewis Amar · Beer Sheva, IL
Rinat Lifshiz · Even Yehuda, IL
Dan Peer · Kiryat Ono, IL

Key dates

Filing date	Feb 5, 2014
Grant date	Feb 14, 2017
Priority date	—
Expiry date	Feb 5, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A complex includes RNA and a positively charged modified polysaccharide selected from starch, amylose, amylopectin, galactan, chitosan, or dextrin. The complex can be formed into a pharmaceutical composition. The complex can be used in methods for RNA transfection, gene therapy and treatment of a disease, disorder or condition. The positively charged modified polysaccharide can be used in connection with RNA transfection into cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.